Evidence map›Paper›PMID 37509273›Full record

ArticleCancers2023

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways.

Mariella Schneider, Melitta B Köpke, Alaleh Zati Zehni, Theresa Vilsmaier, Mirjana Kessler, Magdalena Kailuweit, Aurelia Vattai, Helene Hildegard Heidegger, Vincent Cavaillès, Udo Jeschke and 1 more

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mariella SchneiderDepartment of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany.
Melitta B KöpkeDepartment of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany.ORCID 0000-0002-6463-1499
Alaleh Zati ZehniDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.
Theresa VilsmaierDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.ORCID 0000-0003-0452-1148
Mirjana KesslerDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-9879-1052
Magdalena KailuweitDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.
Aurelia VattaiDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.
Helene Hildegard HeideggerDepartment of Obstetrics and Gynecology, University Hospital Munich, LMU Munich, 81377 Munich, Germany.
Vincent CavaillèsIRCM-Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université Montpellier, Parc Euromédecine, 208 rue des Apothicaires, CEDEX 5, F-34298 Montpellier, France.ORCID 0000-0002-7160-3074
Udo JeschkeDepartment of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany.ORCID 0000-0003-2623-3235
Nina DitschDepartment of Obstetrics and Gynecology, University Hospital Augsburg, 86156 Augsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this retrospective study was to assess the respective prognostic values of cytoplasmic and nuclear TRα, TRα1, and TRα2 expression in breast cancer (BC) tissue samples and correlate the results with clinico-pathological parameters. In 249 BC patients, the expression patterns of general TRα and the α1 and α2 isoforms were evaluated via immuno-histochemistry. Prognosis-determining aspects were calculated via univariate, as well as multivariate, analysis. Univariate Cox-regression analysis revealed no association between nuclear TRα expression and overall survival (OS) (

Indexed as

breast cancerdisease-free survivalimmuno-histochemistryoverall survivalprognosissubcellular localizationthyroid hormone receptorTRαTRα1TRα2

Identifiers

PMID37509273
PMCPMC10377287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.